Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Non-cash Items (2019 - 2023)

Korro Bio's Non-cash Items history spans 5 years, with the latest figure at $4.3 million for Q3 2023.

  • For the quarter ending Q3 2023, Non-cash Items fell 1.15% year-over-year to $4.3 million, compared with a TTM value of $4.3 million through Sep 2023, down 1.15%, and an annual FY2022 reading of $4.6 million, up 14.68% over the prior year.
  • Non-cash Items for Q3 2023 was $4.3 million at Korro Bio, up from $4.2 million in the prior quarter.
  • The five-year high for Non-cash Items was $171.4 million in Q4 2020, with the low at $158890.0 in Q1 2020.
  • Average Non-cash Items over 5 years is $25.5 million, with a median of $4.4 million recorded in 2022.
  • Year-over-year, Non-cash Items soared 34784.51% in 2021 and then crashed 97.69% in 2022.
  • Tracing KRRO's Non-cash Items over 5 years: stood at $73.6 million in 2019, then skyrocketed by 133.02% to $171.4 million in 2020, then plummeted by 77.18% to $39.1 million in 2021, then crashed by 76.7% to $9.1 million in 2022, then crashed by 52.55% to $4.3 million in 2023.
  • Per Business Quant, the three most recent readings for KRRO's Non-cash Items are $4.3 million (Q3 2023), $4.2 million (Q2 2023), and $4.8 million (Q1 2023).